Skip to content

A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

A Survey to Assess the Incidence and Characteristics of Melanoma in Parkinson's Disease Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00203008
Enrollment
2106
Registered
2005-09-20
Start date
2003-01-31
Completion date
2003-09-30
Last updated
2010-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Melanoma, Parkinson's Disease

Brief summary

Patients with Parkinson's disease will be seen by a dermatologist who will biopsy any suspicious skin lesions.

Interventions

None listed

Sponsors

Teva Branded Pharmaceutical Products R&D, Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Confirmed diagnosis Parkinson's disease Patient able and willing to give informed consent Patient must not be taking any investigational drug at the time of enrollment

Exclusion criteria

unconfirmed, undocumented Parkinson's disease unable to give consent taking any investigational product

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026